172 related articles for article (PubMed ID: 21881938)
21. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group.
McDivitt RW; Stevens JA; Lee NC; Wingo PA; Rubin GL; Gersell D
Cancer; 1992 Mar; 69(6):1408-14. PubMed ID: 1540878
[TBL] [Abstract][Full Text] [Related]
22. Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence.
Ogony J; de Bel T; Radisky DC; Kachergus J; Thompson EA; Degnim AC; Ruddy KJ; Hilton T; Stallings-Mann M; Vachon C; Hoskin TL; Heckman MG; Vierkant RA; White LJ; Moore RM; Carter J; Jensen M; Pacheco-Spann L; Henry JE; Storniolo AM; Winham SJ; van der Laak J; Sherman ME
Breast Cancer Res; 2022 Jul; 24(1):45. PubMed ID: 35821041
[TBL] [Abstract][Full Text] [Related]
23. A cohort study of oral contraceptive use and risk of benign breast disease.
Rohan TE; Miller AB
Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
[TBL] [Abstract][Full Text] [Related]
24. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
[TBL] [Abstract][Full Text] [Related]
25. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies.
Baer HJ; Collins LC; Connolly JL; Colditz GA; Schnitt SJ; Tamimi RM
Cancer; 2009 Apr; 115(7):1404-11. PubMed ID: 19170235
[TBL] [Abstract][Full Text] [Related]
26. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.
Aroner SA; Collins LC; Schnitt SJ; Connolly JL; Colditz GA; Tamimi RM
Breast Cancer Res; 2010; 12(4):R61. PubMed ID: 20691043
[TBL] [Abstract][Full Text] [Related]
27. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
[TBL] [Abstract][Full Text] [Related]
28. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
Kabat GC; Jones JG; Olson N; Negassa A; Duggan C; Ginsberg M; Kandel RA; Glass AG; Rohan TE
Cancer Causes Control; 2010 Jun; 21(6):821-8. PubMed ID: 20084540
[TBL] [Abstract][Full Text] [Related]
29. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
Visscher DW; Frank RD; Carter JM; Vierkant RA; Winham SJ; Heinzen EP; Broderick BT; Denison LA; Allers TM; Johnson JL; Frost MH; Hartmann LC; Degnim AC; Radisky DC
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28376198
[TBL] [Abstract][Full Text] [Related]
30. Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.
Román M; Caicoya M; Espinàs J; Sala M; Torá-Rocamora I; Quinta MJ; Vernet M; Saladié F; Romero A; Sánchez M; Baré M; Vidal C; Servitja S; Natal C; Corominas J; Ferrer J; Rodríguez-Arana A; Castells X;
Breast J; 2018 Jul; 24(4):509-518. PubMed ID: 29517151
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.
Rice MS; Tamimi RM; Connolly JL; Collins LC; Shen D; Pollak MN; Rosner B; Hankinson SE; Tworoger SS
Breast Cancer Res; 2012 Mar; 14(2):R44. PubMed ID: 22414675
[TBL] [Abstract][Full Text] [Related]
32. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.
Figueroa JD; Pfeiffer RM; Brinton LA; Palakal MM; Degnim AC; Radisky D; Hartmann LC; Frost MH; Stallings Mann ML; Papathomas D; Gierach GL; Hewitt SM; Duggan MA; Visscher D; Sherman ME
Breast Cancer Res Treat; 2016 Aug; 159(1):163-72. PubMed ID: 27488681
[TBL] [Abstract][Full Text] [Related]
33. The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis.
Zhou WB; Xue DQ; Liu XA; Ding Q; Wang S
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1053-60. PubMed ID: 21499874
[TBL] [Abstract][Full Text] [Related]
34. Pathologic features of breast cancers in women with previous benign breast disease.
Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ
Am J Clin Pathol; 2001 Mar; 115(3):362-9. PubMed ID: 11242792
[TBL] [Abstract][Full Text] [Related]
35. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
36. Model for individualized prediction of breast cancer risk after a benign breast biopsy.
Pankratz VS; Degnim AC; Frank RD; Frost MH; Visscher DW; Vierkant RA; Hieken TJ; Ghosh K; Tarabishy Y; Vachon CM; Radisky DC; Hartmann LC
J Clin Oncol; 2015 Mar; 33(8):923-9. PubMed ID: 25624442
[TBL] [Abstract][Full Text] [Related]
37. Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy.
Mullooly M; Puvanesarajah S; Fan S; Pfeiffer RM; Olsson LT; Hada M; Kirk EL; Vacek PM; Weaver DL; Shepherd J; Mahmoudzadeh A; Wang J; Malkov S; Johnson JM; Hewitt SM; Herschorn SD; Sherman ME; Troester MA; Gierach GL
Cancer Prev Res (Phila); 2019 Dec; 12(12):861-870. PubMed ID: 31645342
[TBL] [Abstract][Full Text] [Related]
38. Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk.
Kensler KH; Liu EZF; Wetstein SC; Onken AM; Luffman CI; Baker GM; Collins LC; Schnitt SJ; Bret-Mounet VC; Veta M; Pluim JPW; Liu Y; Colditz GA; Eliassen AH; Hankinson SE; Tamimi RM; Heng YJ
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2358-2368. PubMed ID: 32917665
[TBL] [Abstract][Full Text] [Related]
39. Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.
Cheng J; Qiu S; Raju U; Wolman SR; Worsham MJ
Breast Cancer Res Treat; 2008 Sep; 111(2):289-96. PubMed ID: 17917807
[TBL] [Abstract][Full Text] [Related]
40. Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning.
de Bel T; Litjens G; Ogony J; Stallings-Mann M; Carter JM; Hilton T; Radisky DC; Vierkant RA; Broderick B; Hoskin TL; Winham SJ; Frost MH; Visscher DW; Allers T; Degnim AC; Sherman ME; van der Laak JAWM
NPJ Breast Cancer; 2022 Jan; 8(1):13. PubMed ID: 35046392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
